Target Selector™ platform shown to be potentially more sensitive than standard-of-care cytology in detecting mutations of brain metastases in cerebrospinal fluid SAN DIEGO, May 29, 2020 /PRNewswire/ - ...
Target Selector™ assay kits enable assay developers to leverage Biocept's patented, high-sensitivity technology for the detection of key actional oncogene mutations from both tissue biopsies and blood ...
“Target Selector is a highly sensitive assay for identifying HER2 status that is less invasive, more time-efficient and more cost-effective than tissue biopsy,” said Michael Dugan, M.D., Biocept’s ...
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, will present data showing that its Target Selector™ molecular assay ...
Quest Diagnostics, a leading provider of diagnostic information services, announced that physicians in the United States can now order the liquid biopsy-based Target Selector NGS Lung Panel test ...
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return ...
Transposons — a class of mobile genetic elements — are widespread in nature, being present in virtually every organism that has been examined. The bacterial transposon Tn7 is of particular interest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback